Cargando…
Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
Tenofovir (TFV) ester prodrugs, a class of nucleotide analogs (NAs), are the first-line clinical anti-hepatitis B virus (HBV) drugs with potent antiviral efficacy, low resistance rate and high safety. In this work, three marketed TFV ester drugs, tenofovir disoproxil fumarate (TDF), tenofovir alafen...
Autores principales: | Hong, Xiaodan, Cai, Zuhuan, Zhou, Fang, Jin, Xiaoliang, Wang, Guangji, Ouyang, Bingchen, Zhang, Jingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465247/ https://www.ncbi.nlm.nih.gov/pubmed/36105197 http://dx.doi.org/10.3389/fphar.2022.932934 |
Ejemplares similares
-
Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBV
por: Puri, Ashana, et al.
Publicado: (2019) -
Straightening the Eyes Doesn't Rebalance the Brain
por: Zhou, Jiawei, et al.
Publicado: (2017) -
Preclinical Pharmacokinetics of C118P, a Novel Prodrug of Microtubules Inhibitor and Its Metabolite C118 in Mice, Rats, and Dogs
por: Zhang, Cang, et al.
Publicado: (2018) -
Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind
por: Cox, Timothy M.
Publicado: (2020) -
Esters of valerenic acid as potential prodrugs
por: Hintersteiner, Juliane, et al.
Publicado: (2014)